NEW DELHI: In a move aimed at improving patient safety, the Central Drugs Standard Control Organisation (CDSCO) has proposed restricting the use of the same brand name for medicines containing different active ingredients, saying the practice can mislead patients and create confusion over their therapeutic use. The regulator has invited public comments on the proposal…